A61P 43 - Drugs for specific purposes, not provided for in groups

Patents for A61P 43 - Drugs for specific purposes, not provided for in groups (156,317)
12/2001
12/13/2001	CA2412377A1 B7-related nucleic acids and polypeptides and their uses for immunomodulation
12/13/2001	CA2412326A1 Stabilized hmg-coa reductase inhibitor pharmaceutical compositions
12/13/2001	CA2411730A1 Tumour suppressor and uses thereof
12/13/2001	CA2411609A1 Isolated human transporter proteins, nucleic acid molecules encoding human transporter proteins, and uses thereof
12/13/2001	CA2411596A1 Therapeutic agents - ii
12/13/2001	CA2411536A1 The use of glatiramer acetate (copolymer 1) in the treatment of central nervous system disorders
12/13/2001	CA2411473A1 Compositions, kits, and methods for identification and modulation of type i diabetes
12/13/2001	CA2411139A1 Inhibitors of c-reactive protein induced inflammation
12/13/2001	CA2411010A1 Tetracyclic diketopiperazine compounds as pdev inhibitors
12/13/2001	CA2410577A1 Method for treating respiratory disorders associated with pulmonary elastic fiber injury
12/13/2001	CA2410509A1 Indolinone derivatives as protein kinase/phosphatase inhibitors
12/13/2001	CA2410188A1 Non-agonistic antibodies to human gp39, compositions containing, and therapeutic use thereof
12/13/2001	CA2410158A1 Protein markers for pharmaceuticals and related toxicity
12/13/2001	CA2409392A1 Intracellular signaling proteins
12/13/2001	CA2409015A1 Caspase inhibitors and uses thereof
12/13/2001	CA2408670A1 Novel compounds of the n-acylamino-amide family, compositions comprising same, and uses
12/13/2001	CA2408542A1 Prostaglandin compounds for treating congestive heart failure
12/13/2001	CA2407164A1 Bicyclic cyclohexylamines and their use as nmda receptor antagonists
12/13/2001	CA2398277A1 The use of copolymer 1 and related peptides and polypeptides and t cells treated therewith for protecting cns cells from glutamate toxicity
12/13/2001	CA2381249A1 Methods and compositions for modulating oxidized ldl transport
12/12/2001	EP1162458A1 Methods and compositions for modulating oxidized LDL transport
12/12/2001	EP1162207A1 Amylin agonist peptides and uses therefor
12/12/2001	EP1162206A2 Peptide nucleic acids
12/12/2001	EP1162201A2 Farnesyl protein transferase inhibiting (imidazol-5-yl)methyl-2-quinolinone derivatives
12/12/2001	EP1162194A1 Factor VIIa inhibitory (thio)urea derivatives, their preparation and their use
12/12/2001	EP1161943A2 Methods for identifying compounds for inhibition of neoplastic lesions, and pharmaceutical compositions containing such compounds
12/12/2001	EP1161687A1 Grb14 and the insulin receptor and screening of novel medicines
12/12/2001	EP1161542A1 Polysaturated fatty acid (pufa) elongase from caenorhabditis elegans
12/12/2001	EP1161449A1 Modulators of beta-amyloid peptide aggregation comprising d-amino acids
12/12/2001	EP1161448A1 49 human secreted proteins
12/12/2001	EP1161446A1 50 human secreted proteins
12/12/2001	EP1161444A1 A novel inhibitor of programmed cell death
12/12/2001	EP1161442A2 Exocytosis pathway proteins and methods of use
12/12/2001	EP1161441A1 Compositions for promoting nerve regeneration
12/12/2001	EP1161439A1 Xylo-lna analogues
12/12/2001	EP1161433A1 Tyrosine kinase inhibitors
12/12/2001	EP1161429A2 Heterocyclic compounds as adenosine deaminase inhibitors
12/12/2001	EP1161428A1 Pyrimidine compounds
12/12/2001	EP1161422A1 Amine derivatives as protease inhibitors
12/12/2001	EP1161421A1 Inhibitors of protein tyrosine phosphatase
12/12/2001	EP1161419A1 Spirocyclic ketones and their use as tachykinin antagonists
12/12/2001	EP1161415A2 N-cyanomethylamides as protease inhibitors
12/12/2001	EP1161412A1 Nuclear receptor arylating compounds
12/12/2001	EP1161280A1 Use of an integrin antagonist and a chemotherapeutic agent in the treatment of neoplasia
12/12/2001	EP1161266A1 Matriptase, a serine protease and its applications
12/12/2001	EP1161261A1 Apoptosis inducing molecule ii and methods of use
12/12/2001	EP1161242A1 Composition and method for treating diabetes
12/12/2001	EP1161237A1 Protease inhibitors
12/12/2001	EP1161236A1 Dihydroxy open-acid and salts of hmg-co-a reductase inhibitors
12/12/2001	EP1161231A2 Method of inhibiting a chaperone protein
12/12/2001	EP1161226A1 Phosphocholine linked prodrug derivatives
12/12/2001	EP0983266B1 novel tetrahydroisoquinolin thiophenecarboximidamides
12/12/2001	EP0981340B1 Pharmaceutical formulations in dry form for the oral administration of a cyclic quaternary ammonium compound
12/12/2001	EP0938471B1 The preparation and use of ortho-sulfonamido aryl hydroxamic acids as matrix metalloproteinase and tace inhibitors
12/12/2001	EP0730465B1 Use of angiotensin iii and analogs thereof in tissue repair
12/12/2001	EP0688213B1 Treatment of tumors with compounds having rxr retinoid receptor agonist activity
12/12/2001	EP0662075B1 Prostaglandin analog for treating osteoporosis
12/12/2001	EP0655921B1 Novel glucan preparation
12/12/2001	EP0646019B1 Biotin-DOTA conjugates and their use in pretargeting methods
12/12/2001	CN1326506A Use of specific hybrid promoters for controlling tissue expression
12/12/2001	CN1326467A Expression and export of angiostation and endostatin as immunofusins
12/12/2001	CN1326459A Heteroaromatic inhibitors of fructose 1,6-bisphosphatase
12/12/2001	CN1326458A CRF receptor antagonists and methods relating thereto
12/12/2001	CN1326457A 4-aminopyrrolopyrimidines as kinase inhibitors
12/12/2001	CN1326456A 8-Azabicyclo [3.,2.1] Oct-2-Ene and-Octane derivatives
12/12/2001	CN1326450A Hydroxyflavone derivatives as tau protein kinase inhibitors
12/12/2001	CN1326441A 4-Aroyl-Piperidin-CCR-3 receptor antagonists III
12/12/2001	CN1326440A Piperdine CCR-3 receptor antagonists
12/12/2001	CN1326362A Model and method for angiogenesis inhibition
12/12/2001	CN1326355A Method of treating heparin-induced thrombocytopenia
12/12/2001	CN1326354A Immortalized human kerationocyte cell line
12/12/2001	CN1326353A Treatment of tumors by administration of growth hormone releasing compounds and their antagonists
12/12/2001	CN1326351A Use of certain drugs for treating nerve root injury
12/12/2001	CN1326349A Antiviral combinations of lamivudine and adefovir
12/12/2001	CN1326345A Compounds for treatment of estrogen-dependent illnesses and methods for making and using same
12/12/2001	CN1326341A Dry powder for inhalation
12/12/2001	CN1326340A Pharmaceutical composition for treatment of acute disorders
12/12/2001	CN1326335A Process for the manufacture of liquid filled capsules
12/12/2001	CN1325717A Health-care food prepared from extracts of animals bone marrow and Chinese-medicinal materials
12/12/2001	CN1325694A Formula and process for preparing charred moxibustion stick
12/11/2001	US6329566 Methods for the detection, treatment, and prevention of neurodegeneration
12/11/2001	US6329542 Preparation of (S)-2-amino-6,6-dimethoxyhexanoic acid methyl ester via novel dioxolanes
12/11/2001	US6329526 Cycloalkyl substituted imidazoles
12/11/2001	US6329524 Cyclic sulfone containing retroviral protease inhibitors
12/11/2001	US6329421 Diaryl bicyclic heterocycles as inhibitors of cyclooxygenase-2
12/11/2001	US6329418 Substituted pyrrolidine hydroxamate metalloprotease inhibitors
12/11/2001	US6329404 Pharmaceutical composition
12/11/2001	US6329402 Heterocycle-containing carboxylic acid derivative and drug containing the same
12/11/2001	US6329397 Hydroxy pipecolate hydroxamic acid derivatives
12/11/2001	US6329394 Medical use for tachykinin antagonists
12/11/2001	US6329392 Substituted piperidines useful for the treatment of allergic diseases
12/11/2001	US6329390 5-Bicycloindole compounds
12/11/2001	US6329388 Thienopyridine compounds, their production and use
12/11/2001	US6329385 Antiinflammatory agents, antiarthritic agents, viral diseases and gastrointestinal disorders
12/11/2001	US6329384 Endothelin antagonist and renin-angiotensin system inhibitor as a combined preparation
12/11/2001	US6329380 Pyrimidine benzimidizazole, pyrimidineimidazole or pyridine imidazole compounds for anticancer agents or atherosclerosis
12/11/2001	US6329374 Non-systemic control of parasites
12/11/2001	US6329373 Metalloproteinase inhibitors
12/11/2001	US6329372 Phenylalanine derivatives
12/11/2001	US6329369 Methods of treating pain and other conditions

1 ... 998 999 1000 1001 1002 1003 1004 1005 1006 1007 1008 1009 1010 1011 1012 1013 1014 1015 1016 1017 1018 ... 1564